These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17109766)

  • 21. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden.
    Mayans S; Lackovic K; Lindgren P; Ruikka K; Agren A; Eliasson M; Holmberg D
    Eur J Hum Genet; 2007 Mar; 15(3):342-6. PubMed ID: 17245407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk.
    Frank B; Bermejo JL; Hemminki K; Sutter C; Wappenschmidt B; Meindl A; Kiechle-Bahat M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
    Carcinogenesis; 2007 Jul; 28(7):1442-5. PubMed ID: 17301065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
    Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
    Kovacs P; Berndt J; Ruschke K; Klöting N; Schön MR; Körner A; Stumvoll M; Blüher M
    Metabolism; 2008 Sep; 57(9):1227-31. PubMed ID: 18702948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
    Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer.
    Goode EL; Szabo C; Prokunina-Olsson L; Vierkant RA; Fredericksen ZS; Collins FS; White KL; Schmidt M; Fridley BL; Couch FJ
    BMC Cancer; 2009 Sep; 9():312. PubMed ID: 19732438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population.
    Ngwa EN; Sobngwi E; Atogho-Tiedeu B; Noubiap JJ; Donfack OS; Guewo-Fokeng M; Mofo EP; Fosso PP; Djahmeni E; Djokam-Dadjeu R; Evehe MS; Aminkeng F; Mbacham WF; Mbanya JC
    BMC Res Notes; 2015 Nov; 8():717. PubMed ID: 26608632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.
    Huertas-Vazquez A; Plaisier C; Weissglas-Volkov D; Sinsheimer J; Canizales-Quinteros S; Cruz-Bautista I; Nikkola E; Herrera-Hernandez M; Davila-Cervantes A; Tusie-Luna T; Taskinen MR; Aguilar-Salinas C; Pajukanta P
    Diabetologia; 2008 Jan; 51(1):62-9. PubMed ID: 17972059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.
    Hazra A; Fuchs CS; Chan AT; Giovannucci EL; Hunter DJ
    Cancer Causes Control; 2008 Nov; 19(9):975-80. PubMed ID: 18478343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer.
    Sevinç A; Yannoukakos D; Konstantopoulou I; Manguoglu E; Lüleci G; Colak T; Akyerli C; Colakoglu G; Tez M; Sayek I; Gerassimos V; Nasioulas G; Papadopoulou E; Florentin L; Kontogianni E; Bozkurt B; Kocabas NA; Karakaya AE; Yulug IG; Ozçelik T
    Anticancer Res; 2004; 24(4):2547-9. PubMed ID: 15330212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
    Frank B; Hemminki K; Meindl A; Wappenschmidt B; Klaes R; Schmutzler RK; Untch M; Bugert P; Bartram CR; Burwinkel B
    Int J Cancer; 2006 May; 118(10):2505-8. PubMed ID: 16353159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population.
    Alami FM; Ahmadi M; Bazrafshan H; Tabarraei A; Khosravi A; Tabatabaiefar MA; Samaei NM
    Genet Mol Biol; 2012 Apr; 35(2):413-7. PubMed ID: 22888288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
    Prokunina-Olsson L; Hall JL
    Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Several type 2 diabetes-associated variants in genes annotated to WNT signaling interact with dietary fiber in relation to incidence of type 2 diabetes.
    Hindy G; Mollet IG; Rukh G; Ericson U; Orho-Melander M
    Genes Nutr; 2016; 11():6. PubMed ID: 27551309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
    Agalliu I; Suuriniemi M; Prokunina-Olsson L; Johanneson B; Collins FS; Stanford JL; Ostrander EA
    Prostate; 2008 May; 68(7):740-7. PubMed ID: 18302196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.
    Connor AE; Baumgartner RN; Baumgartner KB; Kerber RA; Pinkston C; John EM; Torres-Mejia G; Hines L; Giuliano A; Wolff RK; Slattery ML
    Breast Cancer Res Treat; 2012 Nov; 136(2):593-602. PubMed ID: 23085767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCF7L2 gene polymorphisms and susceptibility to breast cancer: a meta-analysis.
    Lu XP; Hu GN; Du JQ; Li HQ
    Genet Mol Res; 2015 Mar; 14(1):2860-7. PubMed ID: 25867435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
    Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
    Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
    Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
    J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.